Cargando…
Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment
Adult T-cell leukaemia/lymphoma (ATLL) is an aggressive malignancy of mature activated T cells caused by human T-cell lymphotropic virus type I (HTLV-1). Prognosis is severe because of intrinsic chemoresistance and severe immuosuppression. Four different subtypes are described with different outcome...
Autores principales: | Marçais, Ambroise, Suarez, Felipe, Sibon, David, Bazarbachi, Ali, Hermine, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504218/ https://www.ncbi.nlm.nih.gov/pubmed/23213552 http://dx.doi.org/10.1155/2012/932175 |
Ejemplares similares
-
ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2014) -
Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma
por: Tsukasaki, Kunihiro, et al.
Publicado: (2020) -
Arsenic trioxide (As(2)O(3)) as a maintenance therapy for adult T cell leukemia/lymphoma
por: Marçais, Ambroise, et al.
Publicado: (2020) -
Can we cure HTLV-I associated Adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2011) -
Recurrent TET2 mutations in adult T cell leukemia
por: Marçais, Ambroise, et al.
Publicado: (2014)